COVID-19 associated mucormycosis and their therapeutics
Mucormycosis has spread rapidly in the COVID-19 and post-COVID-19 patients having low immunity and co-morbidities. It is also related to excessive use of corticosteroids, immunosuppressants, antibiotics, and unhygienic conditions. The efforts have been made to treat COVID-19 and post-COVID-19 associ...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-03-01
|
| Edice: | Heliyon |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2405844026001672 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|